Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7719 USD | +0.47% | +7.21% | +5.02% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.02% | 20.76M | |
+12.94% | 109B | |
+0.91% | 29.93B | |
+12.31% | 22.41B | |
-11.83% | 18.62B | |
-8.62% | 17.11B | |
+15.54% | 16.27B | |
-5.91% | 12.09B | |
+1.93% | 10.87B | |
-15.91% | 8.57B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Holdings Unit Wins Multiple US State Department Contracts Totaling $9 Million; Shares Rise